InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Secora Michael, Chief Financial Officer. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. Cumulatively, 30 disclosures have been published. Activity tracked since 4 February 2022. The latest transaction was filed on 15 November 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Secora Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
11,937 shares@ US$6.1754.1% of flowClass A Common StockSEC:0001601830-24-000214:0
39,375 shares@ US$2.224.8% of flowClass A Common StockSEC:0001601830-24-000204:0
39,375 shares@ US$2.224.7% of flowClass A Common StockSEC:0001601830-24-000176:0
39,375 shares@ US$2.224.7% of flowClass A Common StockSEC:0001601830-24-000156:0
11,962 shares@ US$6.694.3% of flowClass A Common StockSEC:0001601830-24-000125:0
39,375 shares@ US$2.224.7% of flowClass A Common StockSEC:0001601830-24-000123:0
39,375 shares@ US$2.224.8% of flowClass A Common StockSEC:0001601830-24-000101:0
39,375 shares@ US$2.224.8% of flowClass A Common StockSEC:0001601830-24-000083:0
11,962 shares@ US$10.016.5% of flowClass A Common StockSEC:0001601830-24-000056:0
37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001601830-24-000036:0
37,500 shares@ US$2.224.5% of flowClass A Common StockSEC:0001601830-24-000023:0
7,172 shares@ US$12.434.9% of flowClass A Common StockSEC:0001209191-24-003489:0
37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-24-003410:0
8,659 shares0Class A Common StockSEC:0001209191-24-003238:0
37,500 shares@ US$2.224.5% of flowClass A Common StockSEC:0001209191-24-001868:0
37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-058703:0
37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-055610:0
37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-052716:0
37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-049478:0
4,727 shares@ US$9.192.4% of flowClass A Common StockSEC:0001209191-23-046423:0
37,500 shares@ US$2.224.4% of flowClass A Common StockSEC:0001209191-23-042798:0
37,500 shares@ US$2.224.6% of flowClass A Common StockSEC:0001209191-23-037582:0
4,760 shares@ US$5.601.4% of flowClass A Common StockSEC:0001209191-23-030372:0
58,342 shares0Class A Common StockSEC:0001209191-23-026036:0
1,258 shares@ US$8.440.6% of flowClass A Common StockSEC:0001209191-23-010779:0
25 of 30 declarations
About Secora Michael
Secora Michael is Chief Financial Officer at Recursion Pharmaceuticals, INC. on XNAS. The record shows 30 filings in total, and across the 30 sampled filings between 2022-02-08 and 2024-11-19, the most frequent transaction type is option exercise, with buy and sell amounts at EUR 0.
